No article text was recorded for this version.
treatment noncompliance
Version 1 of 120 papers21 conceptsfrozen 2026-10-04
Papers in this version
- Blog: Estimating population average treatment effects from experiments with noncompliance
- Blog: Estimating Individual Treatment Effects through Causal Populations Identification
- Blog: A Finite Population Likelihood Ratio Test of the Sharp Null Hypothesis for Compliers
- Blog: A Clinician’s Tool for Analyzing Non-Compliance
- Blog: MAVIDOS Maternal Vitamin D Osteoporosis Study: study protocol for a randomized controlled trial. The MAVIDOS Study Group
- Blog: Identification of complier and noncomplier average causal effects in the presence of <i>latent</i> missing-at-random (LMAR) outcomes: a unifying view and choices of assumptions
- Blog: Instrument-Armed Bandits
- Blog: Individual Treatment Prescription Effect Estimation in a Low Compliance Setting
- Blog: Effectiveness and safety analysis of Danggui Shaoyao Powder for the treatment of non-alcoholic fatty liver disease: study protocol for a randomized, double-blind, placebo-controlled clinical trial
- Blog: Identification and Estimation of the Probabilities of Potential Outcome Types Using Covariate Information in Studies with Non-compliance
- Blog: Semiparametric Inference of the Complier Average Causal Effect with Nonignorable Missing Outcomes
- Blog: ITT analysis of randomized encouragement design studies with missing data
- Blog: Efficient Adaptive Experimentation with Noncompliance
- Blog: Beyond the Average: Distributional Causal Inference under Imperfect Compliance
- Blog: Instrumental Variable-based Identification for Causal Effects using Covariate Information
- Blog: Methods for Estimating Complier Average Causal Effects for Cost-Effectiveness Analysis
- Blog: Design-Based Theory for Lasso Adjustment in Randomized Block Experiments and Rerandomized Experiments
- Blog: Bounding Causal Effects on Continuous Outcome
- Blog: Better LATE Than Nothing: Some Comments on Deaton (2009) and Heckman and Urzua (2009)
- Blog: Tongmai Yangxin intervening in myocardial remodeling after PCI for coronary heart disease: study protocol for a double-blind, randomized controlled trial
History & citation
Current · Permanent link
Cite this direction
Latest version (a living page):
@misc{lacuna_treatment_noncompliance_273acfea,
title = {treatment noncompliance},
author = {{Lacuna}},
howpublished = {Lacuna research direction},
year = {2026},
url = {https://lacuna.tiptreesystems.com/direction/treatment-noncompliance/rdr_273acfead61c43349c1dd86795fc6f78},
note = {Latest version of a living research direction; cite a version for a fixed text. Accessed 2026-11-20},
}This exact version (version 1, frozen text):
@misc{lacuna_treatment_noncompliance_273acfea_v1,
title = {treatment noncompliance},
author = {{Lacuna}},
howpublished = {Lacuna research direction},
year = {2026},
url = {https://lacuna.tiptreesystems.com/direction/treatment-noncompliance/rdr_273acfead61c43349c1dd86795fc6f78/v/1},
note = {Version 1, frozen 2026-10-04. Accessed 2026-11-20},
}